Category - Pharma Industry News
The Institute of Cancer Research and The Royal Marsden’s new drug combination shows promising results
Teva UK introduces first generic oral anticoagulant
NICE recommends UCB’s Fintepla for Dravet syndrome
Sanofi and Regeneron receives FDA priority review for prurigo nodularis
TauRx shares phase 3 trial data for Alzheimer’s drug
OPEN Health is acquired by Astorg in partnership with Amulet Capital
Genentech’s Evrysdi gets extended FDA approval for spinal muscular atrophy
Sandoz launches ‘Act4Biosimilars’ initiative to address global health inequalities